Increased ATP production during long-term brain ischemia in rats in the presence of propentofylline

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages 33-40

  Plaschke, Konstanze ^a   Bardenheuer, Hubert J ^a   Weigand, Markus A ^a   Martin, Eike ^a   Hoyer, Siegfried ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

(Rat); Adenosine; Brain vessel occlusion; Cerebral cortex; Energy metabolism; Propentofylline

Indexed keywords

ADENOSINE TRIPHOSPHATE; PROPENTOFYLLINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PROTECTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CAROTID ARTERY DISEASES; ENERGY METABOLISM; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAPERITONEAL; MALE; NEUROPROTECTIVE AGENTS; PARIETAL LOBE; RATS; RATS, WISTAR; TEMPORAL LOBE; TIME FACTORS; VERTEBRAL ARTERY; XANTHINES;

EID: 0032524212     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00172-1     Document Type: Article

References (39)

1. Allen K., Busza A.L., Crockard H.A., Frackowiak R.S., Gadian D.G., Proctor E., Russell R.W., Wiliams S.R. Acute cerebral ischaemia: concurrent changes in cerebral blood flow, energy metabolites, pH, and lactate measured with hydrogen clearance and 31P and 1H nuclear magnetic resonance spectroscopy: III. Changes following ischaemia. J. Cereb. Blood Flow Metab. 8:1988;816-821.
2. Andine P., Rudolphi K.A., Fredholm B.B., Hagberg H. Effect of propentophylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischemia. Br. J. Pharmacol. 100:1990;814-818.
3. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 3:1991;213-245.
4. Bergmeyer, H.U., 1974. Methods in Enzymatic Analysis, Vols. 1 and 2. Verlag Chemie/Academic Press, New York.
5. Berne R.M., Rubio R., Curnish R.R. Release of adenosine from ischemic brain. Effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circ. Res. 35:1974;262-271.
6. Buttgereit F., Brand M.D. A hierarchy of ATP-consuming process in mammalian cells. Biochem. J. 312:1995;163-167.
7. Choi D.W. Glutamate neurotoxicity in cortical cell cultures is calcium dependent. Neurosci. Lett. 58:1985;293-297.
8. Corradetti R., Le Conte G., Moroni F., Passani B., Pepeu G. Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol. 104:1984;19-26.
9. De Leo J., Schubert P., Kreutzberg G.W. Propentofylline (HWA 285) protects hippocampal neurons of Mongolian gerbils against damage in the presence of an adenosine antagonist. Neurosci. Lett. 84:1988;307-311.
10. Dux E., Fastbom J., Ungerstedt U., Rudolphi K., Fredholm B.B. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res. 516:1990;248-256.
11. Folbergrova J., Ponten U., Siesjö B.K. Patterns of changes in brain carbohydrate metabolites, amino acids and organic phosphates at increased carbon dioxide tensions. J. Neurochem. 22:1974;1115-1125.
12. Fredholm B.B., Lindgren E. Inhibition of soluble 5′-nucleotidase from rat brain by different xanthine derivatives. Biochem. Pharmacol. 32:1983;2832-2834.
13. Fredholm B.B., Lindström K., Wallman-Johansson A. Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical stimulation of rat hippocampal slices. J. Neurochem. 62:1994;563-573.
14. Hagberg H., Anderson P., Lacarewicz J., Jacobson I., Butcher S., Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49:1987;227-231.
15. Hoyer S., Krier C. Ischemia and the aging brain. Studies on glucose and energy metabolism in rat cerebral cortex. Neurobiol. Aging. 7:1986;23-29.
16. Hudlicka O., Komarek J., Wright A.J.A. The effect of a xanthine derivatives 1-(5 oxohexyl)-3-methyl-7-propylxanthine (HWA 285), on heart performance and regional blood flow in dogs and rabbits. Br. J. Pharmacol. 72:1981;723-730.
17. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
18. Ljunggren B., Schutz H., Siesjö B.K. Changes in energy state and acid-base parameters of the rat brain during complete compression ischemia. Brain Res. 73:1974;277-289.
19. Meyer F.B. Calcium, neuronal hyperexcitability and ischemic injury. Brain Res. Rev. 14:1989;227-243.
20. Miyashita K., Nakajima T., Ishikawa A., Miyatake T. An adenosine uptake blocker, propentofylline, reduces glutamate release in gerbil hippocampus following transient forebrain ischemia. Neurochem. Res. 17:1992;147-150.
21. +-ATP-ase activity. Drug Dev. Res. 6:1985;339-344.
22. Newby A.C. Adenosine and the concept of 'retaliatory metabolites'. Trends Biochem. Sci. 9:1984;42-44.
23. Obrenovitch T.P., Richards D.A. Extracellular neurotransmitter changes in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 7:1995;1-54.
24. Park C.K., Rudolphi K. Antiischemic effects of propentofylline (HWA 285) against focal cerebral infarction in rats. Neurosci Lett. 178:1994;235-238.
25. Parkinson F.E., Rudolphi K.A., Fredholm B.B. Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen. Pharmacol. 25:1994;1053-1058.
26. Petito C.K., Pulsinelli W.A. Sequential development of reversible and irreversible neuronal damage following cerebral ischemia. J. Neuropathol. Exp. Neurol. 43:1993;141-153.
27. Phillis J.W., Smith-Barbour M., O'Regan M.H., Perkins L.M. Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochem. Res. 19:1994;1125-1130.
28. Rother M., Kittner B., Rudolphi K., Rossner M., Labs K.H. HWA 285 (propentofylline) - a new compound for the treatment of both vascular dementia and dementia of the Alzheimer type. Ann. N.Y. Acad. Sci. 777:1996;407-409.
29. Rudolphi K., Schubert P., Parkinson F., Fredholm B. Neuroprotective role of adenosine in cerebral ischemia. TIPS. 13:1992;439-445.
30. Rudolphi K., Schubert P., Parkinson F., Fredholm B. Adenosine and brain ischemia. Brain Metab. Res. Rev. 4:1992;346-369.
31. Schubert P., Rudolphi K.A., Fredholm B.B., Nakamura Y. Modulation of nerve and glial function by adenosine - role in the development of ischemic damage. Int. J. Biochem. 26:1994;1227-1236.
32. Siesjö, B.K., 1978. Brain Energy Metabolism. Wiley, Chichester.
33. Siesjö B.K., Katsuera K., Zhao Q., Folbergrova J. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J. Neurotrauma. 12:1995;943-956.
34. Stefanovich V. Effect of propentofylline on cerebral metabolism of rats. Drug Dev. Res. 6:1985;327-338.
35. Sweeny M.I. Neuroprotective effects of adenosine in cerebral ischemia: Window of opportunity. Neurosci. Biobehav. Rev. 21:1997;207-217.
36. Torigoe R., Hayashi T., Anegawa S., Harada K., Toda K., Maeda K., Katsuragi M. Effect of propentofylline and pentoxifylline on cerebral blood flow using 123I-IMP SPECT in patients with cerebral arteriosclerosis. Clin. Ther. 16:1994;65-73.
37. Tsuji M., Allred E., Jensen F., Holtzman D. Phosphocreatine and ATP regulation in the hypoxic developing rat brain. Brain Res. Dev. Brain Res. 85:1995;192-200.
38. Vukadinovic V., Stefanovich V., Rakic L. Effect of propentofylline on the GABA system of a rat brain. Drug Dev. Res. 7:1986;87-94.
39. Winn H.R., Rubio R., Berne R.M. Brain adenosine concentration during hypoxia in rats. Am. J. Physiol. 241:1981;H235-H242.